• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Trial quality in nephrology: how are we measuring up?

作者信息

Palmer Suetonia C, Sciancalepore Michela, Strippoli Giovanni F M

出版信息

Am J Kidney Dis. 2011 Sep;58(3):335-7. doi: 10.1053/j.ajkd.2011.06.006.

DOI:10.1053/j.ajkd.2011.06.006
PMID:21856491
Abstract
摘要

相似文献

1
Trial quality in nephrology: how are we measuring up?肾脏病学中的试验质量：我们的表现如何？
Am J Kidney Dis. 2011 Sep;58(3):335-7. doi: 10.1053/j.ajkd.2011.06.006.
2
Misuse and reporting of renal endpoints in randomized clinical trials.随机临床试验中肾脏终点指标的误用与报告
Am J Kidney Dis. 2012 Jan;59(1):160; author reply 160-1. doi: 10.1053/j.ajkd.2011.11.009.
3
Loss to analysis in randomized controlled trials in CKD.在 CKD 随机对照试验中的分析损失。
Am J Kidney Dis. 2011 Sep;58(3):349-55. doi: 10.1053/j.ajkd.2011.04.023. Epub 2011 Jul 20.
4
A nephrology guide to reading and using systematic reviews of randomized trials.肾病学系统评价阅读与应用指南：随机试验
Nephrol Dial Transplant. 2015 Jun;30(6):878-84. doi: 10.1093/ndt/gfu222. Epub 2014 Jun 23.
5
Randomized controlled trials in nephrology: state of the evidence and critiquing the evidence.随机对照试验在肾脏病学中的应用：证据现状与评价。
Adv Chronic Kidney Dis. 2012 Jan;19(1):40-6. doi: 10.1053/j.ackd.2012.01.009.
6
Importance of consistent outcomes in randomized controlled trials and systematic reviews about anesthesiology and pain.关于麻醉学与疼痛的随机对照试验及系统评价中一致结果的重要性。
Pain Manag. 2018 Jul 1;8(4):251-253. doi: 10.2217/pmt-2018-0023. Epub 2018 Jun 14.
7
A core set of trial outcomes for every medical discipline?每个医学学科都有一套核心试验结果？
BMJ. 2015 Jan 26;350:h85. doi: 10.1136/bmj.h85.
8
The impact of technology on nephrology social work practice.技术对肾脏病社会工作实践的影响。
Nephrol News Issues. 2013 Apr;27(5):20-2, 24, 26-9.
9
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.随机试验中患者报告结局的报告：CONSORT PRO扩展版
Value Health. 2013 Jun;16(4):455-6. doi: 10.1016/j.jval.2013.04.001.
10
[Outcomes in randomized trials: Typology, relevance and importance for their standardization. Example of renoprotection].[随机试验的结果：分类、相关性及其标准化的重要性。肾脏保护的示例]
Presse Med. 2015 Nov;44(11):1096-102. doi: 10.1016/j.lpm.2015.08.007. Epub 2015 Oct 9.

引用本文的文献

1
Cultivating Innovative, Pragmatic, Randomized Controlled Registry Trials Embedded in Hemodialysis Care: Conference Proceeding From Gardener's Grove 2023.培养嵌入血液透析护理的创新、务实、随机对照注册试验：2023年园丁谷会议论文集
Can J Kidney Health Dis. 2025 Feb 14;12:20543581251318442. doi: 10.1177/20543581251318442. eCollection 2025.
2
The relationship between conference presentations and in-hospital mortality in patients admitted with acute myocardial infarction: A retrospective analysis using a Japanese administrative database.急性心肌梗死入院患者会议报告与院内死亡率之间的关系：使用日本行政数据库的回顾性分析。
PLoS One. 2024 Dec 9;19(12):e0315217. doi: 10.1371/journal.pone.0315217. eCollection 2024.
3
Healthy lifestyle factors as predictors of the initiation of dialysis in people with and without diabetes.
健康生活方式因素作为糖尿病患者和非糖尿病患者开始透析的预测指标。
Diabetol Int. 2024 Jun 25;15(4):786-793. doi: 10.1007/s13340-024-00739-0. eCollection 2024 Oct.
4
New marker for chronic kidney disease progression and mortality in medical-word virtual space.医学字空间中慢性肾脏病进展和死亡的新标志物。
Sci Rep. 2024 Jan 18;14(1):1661. doi: 10.1038/s41598-024-52235-9.
5
eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR > 30 mL/min/1.73 m in the J-DREAMS cohort.在 J-DREAMS 队列中，对于 eGFR>30 mL/min/1.73 m 的糖尿病患者，eGFR 斜率可用作终末期肾病的替代终点。
Clin Exp Nephrol. 2024 Feb;28(2):144-152. doi: 10.1007/s10157-023-02408-z. Epub 2023 Oct 9.
6
Understanding the Current Landscape of Kidney Disease in Canada to Advance Precision Medicine Guided Personalized Care.了解加拿大肾脏疾病的现状以推动精准医学指导下的个性化护理。
Can J Kidney Health Dis. 2023 Feb 13;10:20543581231154185. doi: 10.1177/20543581231154185. eCollection 2023.
7
Effect of canagliflozin on the decline of estimated glomerular filtration rate in chronic kidney disease patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase III study in Japan.卡格列净对 2 型糖尿病合并慢性肾脏病患者估算肾小球滤过率下降的影响：日本多中心、随机、双盲、安慰剂对照、平行分组、III 期研究。
J Diabetes Investig. 2022 Dec;13(12):1981-1989. doi: 10.1111/jdi.13888. Epub 2022 Aug 9.
8
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology.白蛋白尿和估计肾小球滤过率的随机变异对肾脏病学临床试验入组患者和持续时间的影响。
Diabetes Obes Metab. 2022 Jun;24(6):983-990. doi: 10.1111/dom.14660. Epub 2022 Feb 21.
9
Comparison of All-Cause Mortality Between Canadian Kidney Transplant Recipients and Patients With Cancer: A Population-Based Cohort Study.加拿大肾移植受者与癌症患者全因死亡率的比较：一项基于人群的队列研究。
Can J Kidney Health Dis. 2021 Nov 10;8:20543581211056234. doi: 10.1177/20543581211056234. eCollection 2021.
10
Lifestyle behaviors associated with the initiation of renal replacement therapy in Japanese patients with chronic kidney disease: a retrospective cohort study using a claims database linked with specific health checkup results.与日本慢性肾脏病患者开始肾脏替代治疗相关的生活方式行为：使用与特定健康检查结果相关联的索赔数据库进行的回顾性队列研究。
Environ Health Prev Med. 2021 Oct 9;26(1):102. doi: 10.1186/s12199-021-01022-3.